Adenoid cystic carcinoma (ACC) is a rare and aggressive form of cancer that typically arises in the salivary glands, but can also occur in other areas such as the breast, trachea, or lungs. Despite its rarity, ACC poses significant challenges due to its slow growth and tendency to spread to distant organs, particularly the lungs. Research efforts in cancer biology and treatment strategies are intensifying to combat this disease. Scientists are investigating the genetic mutations and molecular pathways underlying ACC to identify potential targets for therapy. Immunotherapy, targeted therapies, and combination treatments are being explored in clinical trials to improve outcomes for patients with ACC. Moreover, advances in precision medicine hold promise for tailoring treatments to the individual characteristics of each patient's tumor, offering new hope in the fight against this challenging cancer.
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : In search of common path in cancerous point mutations
Ratan Kumar Sarkar, Independent Researcher, India
Title : Toll-like receptors-autophagy-PI3Akt “immune-inflammatory metabolic signalosome” in prostate cancer in the robotic prostatectomy golden era: Damage-associated molecular patterns in immunogenic cell-death?
Saumya Pandey, Indira IVF Hospital, India
Title : Revolutionizing psychological care in oncology: A comprehensive review of emerging technologies and their impact on cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : Beauty of herbal medicine in the global fight for cancer
Najjemba Eseza Precious, Mengo Senior School, Uganda